Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy

American Journal of Cardiology

Volumn 115, Issue 9, 2015, Pages 1204-1211

  Franzese, Christopher J ^a   Bliden, Kevin P ^a   Gesheff, Martin G ^a   Pandya, Shachi ^a   Guyer, Kirk E ^b   Singla, Anand ^c   Tantry, Udaya S ^a   Toth, Peter P ^d,e   Gurbel, Paul A ^a  

^a SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

^b INDIANA UNIVERSITY SOUTH BEND   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CGH Medical Center   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 OXOTHROMBOXANE B2; CHOLESTEROL ESTER; COLESEVELAM; COLESTYRAMINE; DOCOSAHEXAENOIC ACID; EZETIMIBE; FIBRIC ACID DERIVATIVE; FIBRIN; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; INTERMEDIATE DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; 11-DEHYDRO-THROMBOXANE B2; BIOLOGICAL MARKER; CHOLESTEROL; LIPOPROTEIN; THROMBOXANE B2;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CASE STUDY; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENSITY GRADIENT CENTRIFUGATION; DIABETES MELLITUS; DIET SUPPLEMENTATION; ELASTICITY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT HISTORY OF CORONARY ARTERY BYPASS GRAFT; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; THROMBOGENICITY; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL; AGED; ANALOGS AND DERIVATIVES; ATHEROSCLEROSIS; BLOOD; METABOLISM; MIDDLE AGED; RISK FACTOR; URINE;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL; CORONARY ARTERY DISEASE; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; FISH OILS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; RISK FACTORS; THROMBELASTOGRAPHY; THROMBOSIS; THROMBOXANE B2; TRIGLYCERIDES;

EID: 84927571473     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.02.002     Document Type: Article

References (25)

1. W.E. Lands, B. Libelt, A. Morris, N.C. Kramer, T.E. Prewitt, P. Bowen, D. Schmeisser, M.H. Davidson, and J.H. Burns Maintenance of lower proportions of (n - 6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fatty acids Biochim Biophys Acta 1180 1992 147 162
2. M.J. James, R.A. Gibson, and L.G. Cleland Dietary polyunsaturated fatty acids and inflammatory mediator production Am J Clin Nutr 71 2000 343S 348S
3. D. Bagga, L. Wang, R. Farias-Eisner, and S.T. Reddy Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion Proc Natl Acad Sci U S A 100 2003 1751 1756
4. K. Vanschoonbeek, M.P. de Maat, and J.W. Heemskerk Fish oil consumption and reduction of arterial disease J Nutr 133 2003 657 660
5. S.D. Kristensen, A.M. Iversen, and E.B. Schmidt n-3 polyunsaturated fatty acids and coronary thrombosis Lipids 36 2001 S79 S82
6. P.A. Gurbel, K.P. Bliden, K. Guyer, P.W. Cho, K.A. Zaman, R.P. Kreutz, A.K. Bassi, and U.S. Tantry Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study J Am Coll Cardiol 46 2005 1820 1826
7. W.S. Harris, J.V. Pottala, R.S. Vasan, M.G. Larson, and S.J. Robins Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans J Nutr 142 2012 1297 1303
8. P.A. Gurbel, K.P. Bliden, J. DiChiara, J. Newcomer, W. Weng, N.K. Neerchal, T. Gesheff, S.K. Chaganti, A. Etherington, and U.S. Tantry Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study Circulation 115 2007 3156 3164
9. K.R. Kulkarni, D.W. Garber, S.M. Marcovina, and J.P. Segrest Quantification of cholesterol in all lipoprotein classes by the VAP-II method J Lipid Res 35 1994 159 168
10. K.R. Kulkarni Cholesterol profile measurement by vertical auto profile method Clin Lab Med 26 2006 787 802
11. H.T. May, J.L. Anderson, R.R. Pearson, J.R. Jensen, B.D. Horne, F. Lavasani, H.D. Yannicelli, and J.B. Muhlestein Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study) Am J Cardiol 101 2008 486 489
12. T.P. Greco, A.M. Conti-Kelly, J.R. Anthony, T. Greco Jr., R. Doyle, M. Boisen, K. Kojima, E. Matsuura, and L.R. Lopez Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes Am J Clin Pathol 133 2010 737 743
13. P.A. Gurbel, K.P. Bliden, K.A. Zaman, J.A. Yoho, K.M. Hayes, and U.S. Tantry Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study Circulation 111 2005 1153 1159
14. W.S. Harris, and D. Bulchandani Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 17 2006 387 393
15. B.A. Griffin, D.J. Freeman, G.W. Tait, J. Thomson, M.J. Caslake, C.J. Packard, and J. Shepherd Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk Atherosclerosis 106 1994 241 253
16. P.T. Williams, H.R. Superko, W.L. Haskell, E.L. Alderman, P.J. Blanche, L.G. Holl, and R.M. Krauss Smallest LDL particles are most strongly related to coronary disease progression in men Arterioscler Thromb Vasc Biol 23 2003 314 321
17. A. Varbo, M. Benn, A. Tybjærg-Hansen, A.B. Jørgensen, R. Frikke-Schmidt, and B.G. Nordestgaard Remnant cholesterol as a causal risk factor for ischemic heart disease J Am Coll Cardiol 61 2013 427 436
18. G. Gajos, J. Zalewski, P. Rostoff, J. Nessler, W. Piwowarska, and A. Undas Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot) Arterioscler Thromb Vasc Biol 31 2011 1696 1702
19. M.K. Larson, G.C. Shearer, J.H. Ashmore, J.M. Anderson-Daniels, E.L. Graslie, J.T. Tholen, J.L. Vogelaar, A.J. Korth, V. Nareddy, M. Sprehe, and W.S. Harris Omega-3 fatty acids modulate collagen signaling in human platelets Prostaglandins Leukot Essent Fatty Acids 84 2011 93 98
20. T.A. Mori, R. Vandongen, F. Mahanian, and A. Douglas Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation Metabolism 41 1992 1059 1067
21. U.S. Tantry, E. Mahla, and P.A. Gurbel Aspirin resistance Prog Cardiovasc Dis 52 2009 141 152
22. Writing Group for the AREDS2 Research Group D.E. Bonds, M. Harrington, B.B. Worrall, A.G. Bertoni, C.B. Eaton, J. Hsia, J. Robinson, T.E. Clemons, L.J. Fine, and E.Y. Chew Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial JAMA Intern Med 174 2014 763 771
23. Y.T. Wen, J.H. Dai, and Q. Gao Effects of omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials Nutr Metab Cardiovasc Dis 24 2014 470 475
24. E.C. Rizos, E.E. Ntzani, E. Bika, M.S. Kostapanos, and M.S. Elisaf Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis JAMA 308 2012 1024 1033
25. J.H. Lee, J.H. O'Keefe, C.J. Lavie, R. Marchioli, and W.S. Harris Omega-3 fatty acids for cardioprotection Mayo Clin Proc 83 2008 324 332